Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Ifosfamide × 90 days × Clear all

Sponsor

Conditions

Sarcoma 5 Sarcoma, Ewing 4 Osteosarcoma 3 Lymphoma, Large B-Cell, Diffuse 3 Sarcoma, Clear Cell 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Lymphoma 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Wilms Tumor 1 Vascular Neoplasms 1 Teratoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Perivascular Epithelioid Cell Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Adipose Tissue 1 Neoplasm Metastasis 1

Interventions

Magnetic Resonance Spectroscopy 5 Biopsy 4 X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 selpercatinib 2 erdafitinib 2 entrectinib 2 ensartinib 2 Radiotherapy 2 Nivolumab 2 Lomustine 2 Etoposide 2 Cyclophosphamide 2 Carboplatin 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 regorafenib 1 perillyl alcohol 1 pemigatinib 1 pembrolizumab 1 pegfilgrastim 1 palbociclib 1 olaparib 1 niraparib 1 lenvatinib 1 larotrectinib 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡